#United States #Denver #Dr. Reju-All #AAD 2026 #K-Pharmacy

Dr. Reju-All Unveils Pharmacist-Led Skincare at AAD 2026

The American Academy of Dermatology (AAD) Annual Meeting 2026 witnessed a significant revelation in the skincare industry with the introduction of Dr. Reju-All, a K-pharmacy skincare brand emphasizing ingredient expertise. This innovative event, held in Denver, attracted an impressive turnout of approximately 4,500 to 5,000 industry professionals, including dermatologists and researchers, who were eager to explore the brand's novel skincare approach.

Dr. Reju-All's launch was not just a presentation but an immersive experience that engaged attendees through a thoughtfully designed booth dedicated to the brand's core philosophy and product offerings. The event aimed to demonstrate how the blend of pharmaceutical knowledge and dermatological practices can create effective skincare solutions.

A Unique Engagement Experience

The Dr. Reju-All booth featured a three-part interactive journey for attendees:

1. Philosophy Showcase: Participants were introduced to the brand's unique formulation framework, designed to enhance ingredient performance through precise concentrations and innovative delivery methods.

2. Product Experience Zone: Attendees had the opportunity to engage directly with the products, focusing on their textures, absorption characteristics, and immediate compatibility with the skin, thereby facilitating a multi-sensory experience.

3. Interactive Learning: To educate the audience further, the booth included an interactive ingredient quiz and a custom gacha activation that highlighted key offerings such as the PDRN Cream and Retino-Mela Serum.

These engaging activities resulted in strong interactions among the dermatology professionals present, who shared independent coverage of the event and significantly raised the brand's profile within the medical skincare community.

Commitment to Research and Development

During the AAD meeting, Dr. Reju-All also unveiled preliminary insights from a forthcoming research paper focusing on PDRN, reinforcing its commitment to enhancing clinical understanding and efficacy of core ingredients used in its products. The data presented was well-received, further establishing the brand's credibility in an increasingly competitive landscape.

The excitement around the product lineup heightened interest in the PDRN Lip Serum, which saw promising early signals of traction in the U.S. market among attendees.

Junho Jung, the founder of Dr. Reju-All, shared his enthusiasm, stating, "Connecting with nearly 5,000 dermatology professionals during our first participation at the AAD was incredibly encouraging. This experience solidified our belief that pharmacist-led formulation can significantly influence the future of dermatological skincare. As we continue to expand into new markets, our focus will remain on advancing scientifically grounded product development."

The Rise of Dr. Reju-All

Founded in mid-2025, Dr. Reju-All represents a transformative shift towards evidence-based skincare, blending the expertise of pharmacist-led formulation with dermatological insights. The brand is dedicated to its philosophy, "The Right Answer to Every Ingredient," which seeks to prioritize efficacy through superior scientific formulation.

Currently, Dr. Reju-All's products are available in over 5,000 pharmacies and clinics across Korea. With its recent expansion efforts aimed at the U.S. market, the brand is set to redefine the beauty standards by promoting the intersection of pharmacological science and skincare.

The success at AAD 2026 visibly positions Dr. Reju-All as a promising player in the realm of clinical skincare, paving the way for future advancements rooted in science and professionalism. As they continue their journey, they emphasize their commitment to educating consumers and professionals alike.

For more information or media inquiries, please contact Jen Betts at (310) 490-7278 or email [email protected]